20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
Bellicum Pharmaceuticals, Inc. - Common Stock (NASDAQ:BLCM) announces its next round of earnings Tuesday. Here is Benzinga's everything-that-matters guide for today's Q4 earnings announcement.
Earnings and Revenue
Analysts are expecting Bellicum Pharmaceuticals to report a loss of 70 cents per share. Revenue will likely be around $840,000, according to the consensus estimate.
In the same quarter last year, Bellicum Pharmaceuticals reported a loss per share of 74 cents on revenue of $81,000.
Here's how the company's EPS has stacked up against analyst estimates in the past:
| Quarter | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 |
| EPS Estimate | -0.74 | -0.66 | -0.7 | -0.7 |
| EPS Actual | -0.71 | -0.74 | -0.8 | -0.74 |
Stock Performance
Over the last 52-week period, shares of Bellicum Pharmaceuticals have declined 39.03 percent. Given that these returns are generally negative, long-term shareholders are probably a little upset going into this earnings release. Long-term shareholders are already wary of 12-month losses prior to the announcement.
Analyst estimates are adjusted higher for EPS and revenues over the past 90 days. The average rating by analysts on Bellicum Pharmaceuticals stock is a Neutral. The validity of this rating has maintained conviction over the past 90 days.
Conference Call
Bellicum Pharmaceuticals Q4 conference call is scheduled to begin at 5:00 p.m. ET and can be accessed here: http://bellicum.equisolvewebcast.com/q4-2017
20-Year Pro Trader Reveals His "MoneyLine"
Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!